uniQure N.V. (QURE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.41 |
| Open | 13.65 |
| Bid | 10.00 x 900 |
| Ask | 18.80 x 1000 |
| Day's range | 13.01 - 13.85 |
| 52-week range | 12.52 - 38.80 |
| Volume | |
| Avg. volume | 522,434 |
| Market cap | 640.005M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 1.99 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Things Look Grim For uniQure N.V. (NASDAQ:QURE) After Today's Downgrade
One thing we could say about the analysts on uniQure N.V. ( NASDAQ:QURE ) - they aren't optimistic, having just made a...
- Zacks
UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
uniQure (QURE) delivered earnings and revenue surprises of -49.25% and 96.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
M&As in Spotlight With GSK Announcement: 3 Biotechs in Focus
We discuss a few companies like uniQure (QURE), CRISPR Therapeutics (CRSP) and Alnylam Pharmaceuticals (ALNY) with solid product portfolios and deep pipelines, which make them attractive candidates for a potential takeover in 2022.
© 2022 Yahoo. All rights reserved.
